(Q38892126)

7 September 2017

1 reference

title

Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring (English)

1 reference

7 September 2017

0 references

cervix uterine cancer

1 reference

Antonia Vlahou

5

0 references

Jerome Zoidakis

series ordinal

2

object named as

Jerome Zoidakis

1 reference

7 September 2017

6

Manousos Makridakis

1 reference

7 September 2017

Georgia Kontostathi

1

1 reference

7 September 2017

Nicholas P Anagnou

series ordinal

3

1 reference

7 September 2017

Kalliopi I Pappa

series ordinal

4

1 reference

7 September 2017

publication date

11 July 2016

1 reference

Expert Review of Proteomics

7 September 2017

published in

1 reference

7 September 2017

volume

13

1 reference

7 September 2017

issue

8

1 reference

7 September 2017

page(s)

731-745

1 reference

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Cross-roads in the classification of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Epithelial cell responses to infection with human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Replication and partitioning of papillomavirus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Biomarkers in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Markers of breast and gynecological malignancies: The clinical approach of proteomics-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Serum biomarkers for early detection of gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

The utility of proteomics in gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Role of proteomics in translational research in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Biomarker discovery for neuroendocrine cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Characterization of Molecular Markers Indicative of Cervical Cancer Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Diagnostic protein marker patterns in squamous cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Expression of heat shock protein 60 kDa is upregulated in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Over-expression of protein kinase C isoforms (α, δ, θ and ζ) in squamous cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic analysis of progressive factors in uterine cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic identification of differentially-expressed proteins in squamous cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Candidates for tumor markers of cervical cancer discovered by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Ultra-sensitive high performance liquid chromatography-laser-induced fluorescence based proteomics for clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Increased cycling cell numbers and stem cell associated proteins as potential biomarkers for high grade human papillomavirus+ve pre-neoplastic cervical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Characterization of the Human Cervical Mucous Proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteome analysis of differential protein expression in cervical cancer cells after paclitaxel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic analysis reveals tanshinone IIA enhances apoptosis of advanced cervix carcinoma CaSki cells through mitochondria intrinsic and endoplasmic reticulum stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Novel semisynthetic derivatives of betulin and betulinic acid with cytotoxic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic investigation into betulinic acid-induced apoptosis of human cervical cancer HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Curcumin targets in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic analysis reveals that pardaxin triggers apoptotic signaling pathways in human cervical carcinoma HeLa cells: cross talk among the UPR, c-Jun and ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

A proteomic investigation into the human cervical cancer cell line HeLa treated with dicitratoytterbium (III) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic analysis of lanthanum citrate-induced apoptosis in human cervical carcinoma SiHa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic analysis of ursolic acid-induced apoptosis in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

HeLa cells 50 years on: the good, the bad and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Identification of cervical cancer proteins associated with treatment with paclitaxel and cisplatin in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Emerging drugs for the treatment of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Addressing the challenge of defining valid proteomic biomarkers and classifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Validation of a multiprotein plasma classifier to identify benign lung nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Identification of HPV integration and gene mutation in HeLa cell line by integrated analysis of RNA-Seq and MS/MS data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Programmable protein arrays for immunoprofiling HPV-associated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Proteomic analysis of cervical cancer cells treated with adenovirus-mediated MDA-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14789450.2016.1210514

Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/PMIC.200900178

10.1080/14789450.2016.1210514

23 March 2024

Identifiers

DOI

1 reference

7 September 2017

1 reference